4/11/2013 6:37:31 AM
Singapore medical device maker Hoya Surgical Optics recalls its intraocular lenses after receiving international reports of higher than expected rates of inflammation and endophthalmitis. Singapore-based Hoya Surgical Optics recalled 5 models of its intraocular lenses after receiving reports of higher-than expected rates of inflammation from doctors in several countries. Healthcare regulators in the U.K. and in Australia have both reported the recall, asking doctors to stop using the implants immediately. The company initially suspended certain shipments of the intraocular implants while it investigated adverse event reports tied to 3 of its lenses: the NY-60, iSert 250 and iSert 251 IOLS.
comments powered by